{"id":560791,"date":"2021-03-14T04:23:33","date_gmt":"2021-03-14T04:23:33","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/"},"modified":"2021-03-14T04:23:33","modified_gmt":"2021-03-14T04:23:33","slug":"gsk-hikma-end-acquisition-talks","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/","title":{"rendered":"GSK, Hikma end acquisition talks"},"content":{"rendered":"

Hikma Pharma won\u2019t be acquiring GlaxoSmithKline\u2019s Egypt unit:<\/strong> GSK and Hikma Pharma have agreed to end talks over a takeover bid submitted in January by the UK-listed company that would have seen it acquire a majority stake in GSK\u2019s Egypt arm, both companies said (here<\/a> and here<\/a> \u2013 pdfs) on Thursday. Hikma will not go through with its mandatory tender offer for the British pharma giant\u2019s distribution and manufacturing business in Egypt.<\/p>\n

What happened?<\/strong> Neither Hikma nor GSK disclosed why the talks broke down. Neither company answered requests for comment.<\/p>\n

Is there a fallback position: <\/strong>Acdima<\/a> and Rameda<\/a> both said they were interested in bidding for GSK\u2019s local arm, but were slapped away by GSK<\/a> last month.<\/p>\n

Background:<\/strong> LSE-listed Hikma Pharma signed a non-binding agreement<\/a> with GSK in late January to acquire its 91.2% stake in its Egypt and Tunisia units. Hikma appointed EFG Hermes as its financial advisor and Sharkawy & Sarhan<\/a> as counsel in preparation for the potential acquisition.<\/p>\n","protected":false},"excerpt":{"rendered":"

Hikma Pharma won\u2019t be acquiring GlaxoSmithKline\u2019s Egypt unit: GSK and Hikma Pharma have agreed to end talks over a takeover bid submitted in January by the UK-listed company that would have seen it acquire a majority stake in GSK\u2019s Egypt arm, both companies said (here and here \u2013 pdfs) on Thursday. Hikma will not go […]<\/p>\n","protected":false},"author":1,"featured_media":560792,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[7363],"tags":[576,136,72,1076,575,7128],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-560791","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ma-watch","tag-banque-misr","tag-ci-capital","tag-enterpriseam","tag-glaxosmithkline","tag-hikma-pharma","tag-ma-watch","wpautop","entry"],"acf":{"mongo_id":"1934c8f6-9bcd-4290-9195-598a2713a15e","is_powered_by":true,"story_type":"1","photo_url":"https:\/\/ent.news\/2021\/3\/185.jpg","photo_position":"above","related_issue":[560784],"teaser":"","voice_url":""},"yoast_head":"\nGSK, Hikma end acquisition talks - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GSK, Hikma end acquisition talks\" \/>\n<meta property=\"og:description\" content=\"Hikma Pharma won\u2019t be acquiring GlaxoSmithKline\u2019s Egypt unit: GSK and Hikma Pharma have agreed to end talks over a takeover bid submitted in January by the UK-listed company that would have seen it acquire a majority stake in GSK\u2019s Egypt arm, both companies said (here and here \u2013 pdfs) on Thursday. Hikma will not go […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-14T04:23:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"GSK, Hikma end acquisition talks\",\"datePublished\":\"2021-03-14T04:23:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/\"},\"wordCount\":168,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1\",\"keywords\":[\"Banque Misr\",\"CI Capital\",\"EnterpriseAM\",\"GlaxoSmithKline\",\"Hikma Pharma\",\"M&A Watch\"],\"articleSection\":[\"M&A WATCH\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/\",\"name\":\"GSK, Hikma end acquisition talks - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1\",\"datePublished\":\"2021-03-14T04:23:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GSK, Hikma end acquisition talks\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GSK, Hikma end acquisition talks - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/","og_locale":"en_US","og_type":"article","og_title":"GSK, Hikma end acquisition talks","og_description":"Hikma Pharma won\u2019t be acquiring GlaxoSmithKline\u2019s Egypt unit: GSK and Hikma Pharma have agreed to end talks over a takeover bid submitted in January by the UK-listed company that would have seen it acquire a majority stake in GSK\u2019s Egypt arm, both companies said (here and here \u2013 pdfs) on Thursday. Hikma will not go […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2021-03-14T04:23:33+00:00","og_image":[{"url":"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1","type":"","width":"","height":""}],"author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"GSK, Hikma end acquisition talks","datePublished":"2021-03-14T04:23:33+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/"},"wordCount":168,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1","keywords":["Banque Misr","CI Capital","EnterpriseAM","GlaxoSmithKline","Hikma Pharma","M&A Watch"],"articleSection":["M&A WATCH"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/","url":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/","name":"GSK, Hikma end acquisition talks - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#primaryimage"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1","datePublished":"2021-03-14T04:23:33+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#primaryimage","url":"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1","contentUrl":"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1"},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"GSK, Hikma end acquisition talks"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?resize=600%2C400&ssl=1","featured_image_src_square":"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?resize=600%2C600&ssl=1","author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":565019,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-is-staying-put-for-now\/","url_meta":{"origin":560791,"position":0},"title":"GSK is staying put \u2014 for now","author":"enterpriseam admin","date":"14 March 2021","format":false,"excerpt":"GSK puts Egypt exit on the backburner: GlaxoSmithKline has shelved plans to sell its units in Egypt and Tunisia following the breakdown of talks with UK-listed Hikma Pharma, the company said in a disclosure (pdf) to the EGX today. The pharma giant initially wanted to sell its entire 91.2% stake\u2026","rel":"","context":"In "SPEED ROUND: M&A WATCH"","block_context":{"text":"SPEED ROUND: M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round-ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":559931,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/02\/09\/gsk-only-has-eyes-for-hikma\/","url_meta":{"origin":560791,"position":1},"title":"GSK only has eyes for Hikma","author":"enterpriseam admin","date":"9 February 2021","format":false,"excerpt":"GlaxoSmithKline (GSK) has rejected separate takeover bids from Rameda and Acdima for its Egypt arm, focusing instead on talks with Hikma Pharma, according to regulatory filings (here and here \u2014 pdfs). GSK said the decision is meant to minimize disruption to the business and save time and resources that would\u2026","rel":"","context":"In "M&A WATCH"","block_context":{"text":"M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/2\/153.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":559722,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/02\/02\/a-bidding-war-for-gsks-egyptian-arm\/","url_meta":{"origin":560791,"position":2},"title":"A bidding war for GSK\u2019s Egyptian arm?","author":"enterpriseam admin","date":"2 February 2021","format":false,"excerpt":"Acdima may have just touched off a bidding war for GlaxoSmithKline's Egypt business, according to a regulatory filing (pdf) yesterday, less than a week after the global player revealed that Hikma was interested in a transaction. Acdima, a pharma industry investor focused on Arab countries, plans to make an offer\u2026","rel":"","context":"In "M&A WATCH"","block_context":{"text":"M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/2\/37.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":565042,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/15\/gsk-egypt-rejects-acdimas-bid-to-start-due-diligence-closing-the-door-to-a-sale\/","url_meta":{"origin":560791,"position":3},"title":"GSK Egypt rejects Acdima\u2019s bid to start due diligence, closing the door to a sale","author":"enterpriseam admin","date":"15 March 2021","format":false,"excerpt":"GlaxoSmithKline Egypt\u2019s board of directors has rejected a request submitted by Acdima to start due diligence on the company, GSK said in an EGXdisclosure (pdf) this morning following a board meeting Sunday. Acdima submitted the request last week following the breakdown of talks between GSK and the UK\u2019s Hikma Pharma.This\u2026","rel":"","context":"In "SPEED ROUND: M&A WATCH"","block_context":{"text":"SPEED ROUND: M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round-ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/3\/473.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":559757,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/02\/03\/rameda-throws-its-hat-in-the-ring-for-gsks-egypt-business\/","url_meta":{"origin":560791,"position":4},"title":"Rameda throws its hat in the ring for GSK\u2019s Egypt business","author":"enterpriseam admin","date":"3 February 2021","format":false,"excerpt":"Ladies and gentlemen, we have a good, old-fashioned bidding war: Rameda Pharma is the latest to show interest in GlaxoSmithKline's Egypt business, joining LSE-listed Hikma Pharma and pharma industry investor Acdima \u2014 who are both planning their own bids. The company has submitted a non-binding letter of interest to GSK\u2026","rel":"","context":"In "M&A WATCH"","block_context":{"text":"M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/2\/58.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":645639,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/07\/26\/eaef-looks-to-buy-orchidia-pharma\/","url_meta":{"origin":560791,"position":5},"title":"EAEF looks to buy Orchidia Pharma","author":"enterpriseam admin","date":"26 July 2017","format":false,"excerpt":"M&A WATCH- Our friends at the Egyptian American Enterprise Fund (EAEF) are reportedly planning to invest in Orchidia Pharma, sources close to the matter tell Al Borsa. While EAEF is hoping to acquire up to 100% of the company, it would settle on a majority stake of 55%, the sources\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/560791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=560791"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/560791\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/560784"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media\/560792"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=560791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=560791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=560791"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=560791"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=560791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}